Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-01-05 @ 5:49 PM
Study NCT ID:
NCT07010432
Status:
RECRUITING
Last Update Posted:
2025-07-25
First Post:
2025-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2028-05-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-05-03
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-30
First Submit QC Date:
None
Study First Post Date:
2025-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-22
Last Update Post Date:
2025-07-25
Last Update Post Date Type:
ACTUAL